DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/19961
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJain, Ankit-
dc.date.accessioned2025-11-06T04:13:22Z-
dc.date.available2025-11-06T04:13:22Z-
dc.date.issued2025-06-
dc.identifier.urihttps://shop.elsevier.com/books/tumor-targeting-with-stimuli-responsive-vesicular-nanocarriers/jain/978-0-443-29125-8-
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/19961-
dc.description.abstractTumour-Targeting with Stimuli Responsive Vesicular Nanocarriers: Basics to Emerging Applications not only acquaints scientists and science interns with the fundamental knowledge of the experimental aspects and state-of-the-art technology for vesicular carriers to equip their rational application in tumor targeting, but also provides a holistic understanding of regulatory concerns, patents, and clinical trials. In 15 chapters. this book provides basics and advances in stimuli-responsive vesicular carriers for tumor targeting based on findings outlined in highly organized tables, illustrative figures, and flow charts. With a focus on the extrapolation of bioengineering tools in the domain of vesicular carriers, stimuli-responsive features concerning tumors, drug delivery approaches, and associated challenges, it helps readers to define the major gaps in knowledge that can lead to significant scientific discoveries in therapy, diagnosis, and theragnosis of cancer.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectPharmacy Departmenten_US
dc.subjectStimuli-responsive nanocarriersen_US
dc.subjectTumour-targetingen_US
dc.subjectVesicular carriersen_US
dc.subjectCancer therapyen_US
dc.titleTumor-targeting with stimuli-responsive vesicular nanocarriers: basics to emerging applicationsen_US
dc.typeBooken_US
Appears in Collections:Department of Pharmacy

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.